Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
BMC Medical Genomics|December 29, 2018
Analytical validation of a prognostic prostate cancer gene expression assay using formalin fixed paraffin embedded tissuePaul Wallace Medlow, Christopher James Steele, Andrena Marie McCavigan, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 21, 2016
The Association of Peripheral Blood Regulatory T-Cell Concentrations With Epithelial Ovarian Cancer: A Brief ReportRikki A Cannioto, Lara E Sucheston-Campbell, Shalaka Hampras, et al.
British Journal of Sports Medicine|July 28, 2018
Concussion management in combat sports: consensus statement from the Association of Ringside PhysiciansJohn Neidecker, Nitin K Sethi, Randolph Taylor, et al.
Addiction (Abingdon, England)|May 31, 2016
Improving the delivery of brief interventions for heavy drinking in primary health care: outcome results of the Optimizing Delivery of Health Care Intervention (ODHIN) five-country cluster randomized factorial trialPeter Anderson, Preben Bendtsen, Fredrik Spak, et al.
Implementation Science : IS|July 17, 2016
Impact of primary healthcare providers' initial role security and therapeutic commitment on implementing brief interventions in managing risky alcohol consumption: a cluster randomised factorial trialM Keurhorst, P Anderson, M Heinen, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|March 20, 2015
Professional's Attitudes Do Not Influence Screening and Brief Interventions Rates for Hazardous and Harmful Drinkers: Results from ODHIN StudyPreben Bendtsen, Peter Anderson, Marcin Wojnar, et al.
Plos Medicine|December 19, 2018
Effectiveness and treatment moderators of internet interventions for adult problem drinking: An individual patient data meta-analysis of 19 randomised controlled trialsHeleen Riper, Adriaan Hoogendoorn, Pim Cuijpers, et al.
Lancet (London, England)|September 21, 2025
Once-daily oral icotrokinra versus placebo and once-daily oral deucravacitinib in participants with moderate-to-severe plaque psoriasis (ICONIC-ADVANCE 1 & 2): two phase 3, randomised, placebo-controlled and active-comparator-controlled trialsLinda Stein Gold, April W Armstrong, Robert Bissonnette, et al.
Pageof 9